Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02395614 · ClinicalTrials.gov registry record · NA
Surgical Site Infection With 0.05% Chlorhexidine (CHG) Compared to Triple Antibiotic Irrigation
A NA study, sponsored by Vanderbilt University Medical Center.
- Completed
- Registry status
- NA
- Development phase
- 88
- Enrollment target
NCT02395614 is a NA study that has completed, run by Vanderbilt University Medical Center. The registered enrollment target is 88 participants.
The verdict
NCT02395614, a NA study, has completed, sponsored by Vanderbilt University Medical Center.
- COMPLETED
- Registry status
- NA
- Development phase
- 88 participants
- Enrollment target
Study Summary
The investigators intend to perform a prospective randomized study and compare the incidence of surgical wound infection between mastectomy wounds irrigated with triple antibiotic solution (one side) and 0.05% CHG (opposite side) in patients undergoing bilateral breast reconstruction. Each patient will receive triple antibiotic solution on one breast and the CHG on the other breast.
Interventions
- DRUG Chlorhexidine irrigation
- DRUG triple antibiotic irrigation
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 88 participants |
| Start Date | 2015-12 |
| Est. Completion | 2020-12 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02395614
The ClinicalTrials.gov registry entry for NCT02395614 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 88 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Vanderbilt University Medical Center, which has 677 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Chlorhexidine irrigation is the first listed.
NCT02395614 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02395614 about?
NCT02395614 is a clinical study titled "Surgical Site Infection With 0.05% Chlorhexidine (CHG) Compared to Triple Antibiotic Irrigation". The investigators intend to perform a prospective randomized study and compare the incidence of surgical wound infection between mastectomy wounds irrigated with triple antibiotic solution (one side) and 0.05% CHG (opposite side) in patients undergoing bilateral breast reconstruction. Each patient w...
What is the current status of trial NCT02395614?
This trial is currently completed. It is a NA study. The enrollment target is 88 participants. The study started on 2015-12. Estimated completion is 2020-12.
What interventions are being tested in trial NCT02395614?
The interventions under investigation include: Chlorhexidine irrigation (DRUG), triple antibiotic irrigation (DRUG).
Who is sponsoring clinical trial NCT02395614?
This trial is sponsored by Vanderbilt University Medical Center, which has 677 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.